Bridging Healthcare Innovation and the Business of Medicine with Roger Owens, Chief Commercial Officer at Ultromics

Finding heart failure earlier gives patients a better chance to begin treatment before the disease progresses. In this episode, Roger Owens, Chief Commercial Officer at Ultromics, discusses how AI-powered echocardiography can improve the early detection of HFpEF and cardiac amyloidosis. He explains how EchoGo integrates seamlessly into existing hospital workflows, enabling physicians to identify signs of heart failure from standard echocardiograms. Roger also explores the operational, reimbursement, and implementation challenges healthcare organizations face when adopting AI in clinical practice. He emphasizes that advances in treatment options make earlier diagnosis increasingly important for improving patient outcomes. Tune in to discover how AI-powered cardiac diagnostics can support earlier intervention and better patient outcomes! Resources: Connect with and follow Roger Owens on LinkedIn. Follow Ultromics on LinkedIn and explore their website!